Your browser doesn't support javascript.
loading
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy.
Wang, Wei; Hao, Yuhao; Liu, Yusheng; Li, Rui; Huang, Da-Bing; Pan, Yue-Yin.
Afiliación
  • Wang W; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Hao Y; Department of Chemistry, University of Science and Technology of China, Hefei, China.
  • Liu Y; Department of Chemistry, University of Science and Technology of China, Hefei, China.
  • Li R; Department of Chemistry, University of Science and Technology of China, Hefei, China.
  • Huang DB; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Pan YY; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Wiley Interdiscip Rev Nanomed Nanobiotechnol ; 13(1): e1654, 2021 01.
Article en En | MEDLINE | ID: mdl-32700465
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Pulmonares / Neoplasias Idioma: En Revista: Wiley Interdiscip Rev Nanomed Nanobiotechnol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Pulmonares / Neoplasias Idioma: En Revista: Wiley Interdiscip Rev Nanomed Nanobiotechnol Año: 2021 Tipo del documento: Article